Exercise and RIC and TCD
The Effects of Acute Exercise and Remote Ischaemic Conditioning (RIC) on Cerebral Blood Flow Velocity in Patients With Ischaemic Stroke and Healthy Controls
1 other identifier
interventional
10
1 country
1
Brief Summary
The first week after a stroke is a particularly important time, as improving blood flow may limit secondary ischaemic damage to the brain and help reduce the overall burden neurological injury and future disability. Small studies in patients with stroke have shown that moderate aerobic exercise increases blood flow to the brain, however, no studies have evaluated the safety of aerobic exercise within the first week after stroke, nor whether it results in changes to cerebral blood flow. Remote ischaemic conditioning (RIC) is when ischaemia is induced to a limb for short periods of time by inflating pressure cuffs around arms or legs to above systolic pressures (mmHg). This procedure is performed for periods that avoid physical injury to the limbs, but induce neurohormonal, systemic or vascular changes in the body. These changes often result in improved blood supply to various areas of the body. The use of RIC in the acute period after stroke is currently being investigated in a number of large randomised controlled trials e.g. RECAST, RESIST, however, our understanding of how RIC actually works is incomplete. Importantly, there is scarce data on the acute effects of RIC on cerebral blood flow (CBF), a potentially pivotal mechanism behind its effects. We propose an exploratory study to evaluate whether it is feasible, acceptable and safe to undertake low and moderate intensity aerobic exercise or remote ischaemic conditioning (RIC) in patients during the acute period after stroke, and whether either of these interventions result in changes to cerebral blood flow velocity (CBFv) in the major cerebral arteries. We will compare any changes to those in a cohort of healthy volunteers.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Jun 2019
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
May 28, 2019
CompletedFirst Posted
Study publicly available on registry
May 30, 2019
CompletedStudy Start
First participant enrolled
June 7, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
December 31, 2021
CompletedJanuary 3, 2024
January 1, 2024
2.6 years
May 28, 2019
January 2, 2024
Conditions
Outcome Measures
Primary Outcomes (6)
Number of Incidences of RICTreatment-Emergent Adverse Events.
Safety of the RIC intervention will be assessed by measuring the Number of Adverse Events experienced by participants that are related to the RIC intervention.
48 hours
Number of Incidences of Exercise Treatment-Emergent Adverse Events.
Safety of the exercise intervention will be assessed by measuring the Number of Adverse Events experienced by participants that are related to the exercise intervention.
48 hours
Number of participants reporting RIC associated discomfort on a likert scale
Reported grade of discomfort associated with RIC will be measured on a likert scale of 0-5, 1 being very uncomfortable to 5 being very comfortable. Acceptance of RIC will be defined as an average score of \>3/5 on the likert scale.
48 hours
Number of participants reporting exercise associated discomfort on a likert scale
Reported grade of discomfort associated with exercise will be measured on a likert scale of 0-5, 1 being very uncomfortable to 5 being very comfortable. Acceptance of exercise will be defined as an average score of \>3/5 on the likert scale.
48 hours
% of RIC intervention completed and recorded
Feasibility of RIC will be defined as \>80% of the intervention being completed and recorded.
48 hours
% of exercise intervention completed and recorded
Feasibility of exercise will be defined as \>80% of the intervention being completed and recorded.
48 hours
Secondary Outcomes (1)
Change from baseline in cerebral blood flow velocity.
48 hours
Study Arms (2)
Exercise
EXPERIMENTALRemote Ischaemic Conditioning
EXPERIMENTALInterventions
Patients will undergo 30 minutes of light-moderate intensity leg cycling, using the Letto-2 (Motomed, UK) in the semi-supine position.
Patients will undergo 4 cycles of upper limb RIC using a blood pressure cuff. Each cycle will involve inflating the blood pressure cuff to 200 mmHg for five minutes around the upper arm, followed by a period of relaxation of the cuff for a further 5 minutes. The total RIC treatment time will take 40 minutes.
Eligibility Criteria
You may qualify if:
- Adult (age \> 18) patients who have suffered acute ischaemic stroke between 2-7 days previously, or healthy adult (\>18 years).
- Ability to provide written informed consent
- Ability to mobilise lower body limbs (at least one leg)
- Ability to comply with study procedures in the opinion of the treating physician.
You may not qualify if:
- Haemorrhagic Stroke
- Ischaemic stroke \< 2 days or \>10 days
- Disability preventing lower extremity cycling
- New York Heart Failure Classification stage III/IV
- History of ischaemic stroke
- Current diagnosis of cancer
- Resting Blood pressure \> 180 / 100 mmHg
- Clinically unstable
- History or presence of significant peripheral vascular disease in the upper limbs.
- History or presence of complex neuropathic pains or peripheral neuropathy in the arms.
- Presence of lymphoedema in the arms.
- Presence of skin ulceration to the arms.
- Uncontrolled arrhythmia, hypertension, diabetes or angina.
- Acute deep vein thrombosis, pulmonary embolism or pulmonary infection.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Sheffield Teaching Hospitals NHS FT
Sheffield, United Kingdom
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Ali Ali, MD
Sheffield Teaching Hospitals NHS Foundation Trust
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NON RANDOMIZED
- Masking
- NONE
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
May 28, 2019
First Posted
May 30, 2019
Study Start
June 7, 2019
Primary Completion
December 31, 2021
Study Completion
December 31, 2021
Last Updated
January 3, 2024
Record last verified: 2024-01